What is the share price of Indraprastha Medical Corporation Ltd (INDRAMEDCO) today?
The share price of INDRAMEDCO as on 23rd May 2025 is ₹414.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The past returns of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share are- Past 1 week: 1.73%
- Past 1 month: -2.69%
- Past 3 months: 4.54%
- Past 6 months: -1.11%
- Past 1 year: 69.36%
- Past 3 years: 609.76%
- Past 5 years: 1015.75%
What are the peers or stocks similar to Indraprastha Medical Corporation Ltd (INDRAMEDCO)?
The peers or stocks similar to Indraprastha Medical Corporation Ltd (INDRAMEDCO) include:What is the dividend yield % of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The current dividend yield of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 1.09.What is the market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹3799.85 Cr as of 23rd May 2025.What is the 52 week high and low of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The 52-week high of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹572 and the 52-week low is ₹211.30.What is the PE and PB ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) stock?
The P/E (price-to-earnings) ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 23.60. The P/B (price-to-book) ratio is 7.95.Which sector does Indraprastha Medical Corporation Ltd (INDRAMEDCO) belong to?
Indraprastha Medical Corporation Ltd (INDRAMEDCO) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares?
You can directly buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Indraprastha Medical Corporation Ltd
INDRAMEDCO Share Price
How to use scorecard? Learn more
INDRAMEDCO Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
23.60 | 7.95 | 1.09% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
37.78 | 6.46 | 0.86% |
INDRAMEDCO Analyst Ratings & Forecast
Detailed Forecast from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
INDRAMEDCO Company Profile
Indraprastha Medical Corporation Limited is engaged in healthcare business.
INDRAMEDCO Similar Stocks (Peers)
Compare with peersINDRAMEDCO Forecasts
INDRAMEDCO Forecast
Price
Revenue
Earnings
INDRAMEDCO Share Price Forecast
All values in ₹
All values in ₹
INDRAMEDCO Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
INDRAMEDCO Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
INDRAMEDCO
Income
Balance Sheet
Cash Flow
INDRAMEDCO Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 766.18 | 753.45 | 788.64 | 831.46 | 614.06 | 891.28 | 1,108.70 | 1,261.59 | 1,379.01 | 1,379.01 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,112.09 | 1,112.09 | ||||||||||
Power & Fuel Cost | 20.91 | 19.26 | 19.70 | 21.16 | 17.18 | 20.56 | 22.74 | 26.01 | ||||||||||||
Employee Cost | 190.26 | 194.01 | 200.21 | 213.93 | 197.71 | 213.92 | 246.70 | 261.61 | ||||||||||||
Selling & Administrative Expenses | 76.58 | 72.29 | 78.20 | 83.66 | 186.62 | 292.12 | 407.26 | 462.43 | ||||||||||||
Operating & Other expenses | 399.17 | 394.31 | 409.28 | 425.63 | 171.60 | 247.26 | 271.27 | 301.29 | ||||||||||||
EBITDA | 79.26 | 73.58 | 81.25 | 87.08 | 40.95 | 117.42 | 160.73 | 210.25 | 266.92 | 266.92 | ||||||||||
Depreciation/Amortization | 30.53 | 30.68 | 29.75 | 32.97 | 33.32 | 34.94 | 39.27 | 40.08 | 44.33 | 44.33 | ||||||||||
PBIT | 48.73 | 42.90 | 51.50 | 54.11 | 7.63 | 82.48 | 121.46 | 170.17 | 222.59 | 222.59 | ||||||||||
Interest & Other Items | 7.91 | 8.90 | 6.87 | 5.92 | 3.34 | 3.41 | 4.28 | 4.06 | 6.27 | 6.27 | ||||||||||
PBT | 40.82 | 34.00 | 44.63 | 48.19 | 4.29 | 79.07 | 117.18 | 166.11 | 216.32 | 216.32 | ||||||||||
Taxes & Other Items | 14.57 | 12.90 | 16.21 | 4.57 | 1.96 | 20.45 | 31.03 | 42.15 | 55.33 | 55.33 | ||||||||||
Net Income | 26.25 | 21.10 | 28.42 | 43.62 | 2.33 | 58.62 | 86.15 | 123.96 | 160.99 | 160.99 | ||||||||||
EPS | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 | 17.56 | ||||||||||
DPS | 1.80 | 1.50 | 1.60 | 0.00 | 0.00 | 2.50 | 3.00 | 4.50 | 4.50 | 4.50 | ||||||||||
Payout ratio | 0.63 | 0.65 | 0.52 | 0.00 | 0.00 | 0.39 | 0.32 | 0.33 | 0.26 | 0.26 |
INDRAMEDCO Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFINDRAMEDCO Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Indraprastha Medical Corporation Ltd | 23.60 | 7.95 | 1.09% |
Max Healthcare Institute Ltd | 103.75 | 13.28 | 0.13% |
Apollo Hospitals Enterprise Ltd | 111.28 | 13.66 | 0.23% |
Fortis Healthcare Ltd | 70.58 | 6.39 | 0.14% |
INDRAMEDCO Stock Price Comparison
Compare INDRAMEDCO with any stock or ETFINDRAMEDCO Shareholdings
INDRAMEDCO Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
INDRAMEDCO Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDRAMEDCO Shareholding Pattern
INDRAMEDCO Shareholding History
Mutual Funds Invested in INDRAMEDCO
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 2 Mutual Funds holding Indraprastha Medical Corporation Ltd
Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4982% | Percentage of the fund’s portfolio invested in the stock 0.36% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 60/103 (+12) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0007% | Percentage of the fund’s portfolio invested in the stock 0.14% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 65/109 (-3) |
Compare 3-month MF holding change on Screener
smallcases containing INDRAMEDCO stock
Looks like this stock is not in any smallcase yet.
INDRAMEDCO Events
INDRAMEDCO Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
INDRAMEDCO Upcoming Dividends
No upcoming dividends are available
INDRAMEDCO Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Dividend/Share
₹4.50
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 15, 2023
Dividend/Share
₹3.00
Ex DateEx Date
Sep 15, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateSep 12, 2019
Dividend/Share
₹1.60
Ex DateEx Date
Sep 12, 2019
Cash Dividend
Ex DateEx DateSep 12, 2018
Dividend/Share
₹1.50
Ex DateEx Date
Sep 12, 2018
INDRAMEDCO Stock News & Opinions
Indraprastha Medical Corporation announced that the Board of Directors of the Company at its meeting held on 16 May 2025, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 45%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of Indraprastha Medical Corporation rose 31.57% to Rs 41.01 crore in the quarter ended March 2025 as against Rs 31.17 crore during the previous quarter ended March 2024. Sales rose 6.04% to Rs 333.75 crore in the quarter ended March 2025 as against Rs 314.73 crore during the previous quarter ended March 2024. For the full year,net profit rose 29.87% to Rs 160.99 crore in the year ended March 2025 as against Rs 123.96 crore during the previous year ended March 2024. Sales rose 8.97% to Rs 1356.36 crore in the year ended March 2025 as against Rs 1244.70 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales333.75314.73 6 1356.361244.70 9 OPM %18.3715.39 -18.0115.53 - PBDT66.1851.77 28 260.65206.19 26 PBT55.2741.56 33 216.32166.11 30 NP41.0131.17 32 160.99123.96 30 Powered by Capital Market - Live
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live
The agency has also affirmed the company's short term rating at '[ICRA] A1+'. ICRA stated that the rating action factors in Indraprastha Medical Corporation Limited (IMCL)'s established presence and strong market position in the NCR region, its healthy operating metrics and its robust financial profile. The ratings also factor in IMCL's revenue diversification across specialities, including oncology, neurology, cardiology and nephrology, among others. The financial risk profile remains comfortable as reflected by minimal gearing, robust debt protection indicators and a strong liquidity profile. Further, the ratings factor in the strong parentage of Apollo Hospitals Enterprise Limited (AHEL) along with its promoters, holding a 25% stake in IMCL. The entity has significant operational, financial and managerial linkages with AHEL. Apollo Hospitals is among the leading healthcare players, operating one of the largest hospital chains in the country. However, the ratings remain constrained by the geographical and asset concentration risks, as IMCL's operations are concentrated across two hospitals in the National Capital Region (NCR). Like other entities in the sector, IMCL remains exposed to regulatory risks, with previous restrictions imposed by various authorities. The ratings also factor in the competitive pressures and the necessity to retain medical talent in an ever-evolving market. Incorporated in 1988 as a JV between Apollo Hospitals Enterprise (AHEL) and the Delhi Government, Indraprastha Medical Corporation (IMCL) is a 749-bedded, super speciality tertiary care hospital in New Delhi and Noida. The scrip gained 3.09% to currently trade at Rs 415.30 on the BSE. Powered by Capital Market - Live
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 3 February 2025.Powered by Capital Market - Live
Net profit of Indraprastha Medical Corporation rose 29.07% to Rs 42.40 crore in the quarter ended September 2024 as against Rs 32.85 crore during the previous quarter ended September 2023. Sales rose 10.35% to Rs 349.82 crore in the quarter ended September 2024 as against Rs 317.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales349.82317.00 10 OPM %18.1915.89 - PBDT68.1053.68 27 PBT56.9343.65 30 NP42.4032.85 29 Powered by Capital Market - Live
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live
Indraprastha Medical Corporation announced that the 36th Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live
Net profit of Indraprastha Medical Corporation rose 46.79% to Rs 44.77 crore in the quarter ended June 2024 as against Rs 30.50 crore during the previous quarter ended June 2023. Sales rose 13.49% to Rs 347.86 crore in the quarter ended June 2024 as against Rs 306.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales347.86306.51 13 OPM %19.3015.42 - PBDT70.6350.04 41 PBT59.5940.23 48 NP44.7730.50 47 Powered by Capital Market - Live
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 9.85%, vs industry avg of 10.01%
Over the last 5 years, market share decreased from 2.15% to 1.98%
Over the last 5 years, net income has grown at a yearly rate of 34.26%, vs industry avg of 42.91%